Clinical Trial Results:
A Phase II/III Randomized, Double-Blind Study of Paclitaxel plus Carboplatin in
Combination with Vorinostat (MK-0683) or Placebo in Patients with Stage IIIB (with
pleural effusion) or Stage IV Non-Small-Cell Lung Cancer (NSCLC)
Summary
|
|
EudraCT number |
2006-005122-23 |
Trial protocol |
CZ DE FI DK GB SE IT LV |
Global completion date |
12 Dec 2008
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
31 Jul 2016
|
First version publication date |
31 Jul 2016
|
Other versions |
|
Summary report(s) |
clinicaltrials.gov record including results |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.